Conversely, the proportion of apoptosis of bladder cancer cells overexpressing IGF2BP3 was significantly reduced, further confirming that IGF2BP3 knockdown can increase the sensitivity of bladder cancer to cisplatin chemotherapy (Figure 4C-D). Here, IGF2BP3 is linked to urinary bladder cancer.